BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
Presentation will be Web cast live
LAVAL, QC, May 15 /CNW Telbec/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX:
BLU, formerly known as Neurochem Inc.) announces today that on Monday, May 19,
2008, Dr. Francesco Bellini, BELLUS Health's Chairman, President and Chief
Executive Officer will present BELLUS Health's strategy at the Rodman and
Renshaw 5th Annual Global Healthcare Conference to be held at the Le Meridien
Beach Plaza Hotel Monte Carlo, Monaco. The presentation will take place at
11:05 A.M. CEST (05:05 A.M. EDT).
The live Web cast of BELLUS Health's presentation (audio and visual) can
be accessed at http://www.wsw.com/webcast/rrshq13/blus/. A replay of the
presentation will begin three (3) hours after the actual presentation time,
and will be available until May 26, 2008. Please access the Web cast
approximately 15 minutes before the presentation is scheduled to begin.
About BELLUS Health
BELLUS Health is a global health company focused on the development and
commercialization of products to provide innovative health solutions to
address critical unmet medical needs.
To Contact BELLUS Health
For additional information on BELLUS Health and its programs, please call
the Canada and United States toll-free number 1-877-680-4500 or visit the Web
Site at www.bellushealth.com.
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond BELLUS Health
Inc.'s (formerly known as Neurochem Inc.) control. Such risks include but are
not limited to: the impact of general economic conditions, general conditions
in the pharmaceutical and/or nutraceutical industry, changes in the regulatory
environment in the jurisdictions in which the BELLUS Health group does
business, stock market volatility, fluctuations in costs, and changes to the
competitive environment due to consolidation, that actual results may vary
once the final and quality-controlled verification of data and analyses has
been completed, as well as other risks disclosed in public filings of BELLUS
Health Inc. Consequently, actual future results may differ materially from the
anticipated results expressed in the forward-looking statements. The reader
should not place undue reliance, if any, on any forward-looking statements
included in this news release. These statements speak only as of the date made
and BELLUS Health Inc. is under no obligation and disavows any intention to
update or revise such statements as a result of any event, circumstances or
otherwise, unless required by applicable legislation or regulation. Please see
the Annual Information Form of BELLUS Health Inc. for further risk factors
that might affect the BELLUS Health group and its business.
For further information: Lise Hébert, Ph.D., Vice President, Corporate Communications, (450) 680-4572, lhebert@bellushealth.com
Index of Releases